COMPANY PROFILE

Flame Biosciences

Explore full profile

Flame Biosciences | Inflammasome Therapies Research, Development, and Commercialization

New York City, United StatesFounded 2017Biotech & Life Sciences

Valuation $250–500M Last recorded · 2020

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Flame Biosciences

Flame Biosciences is a biotechnology company focused on developing high-value medicines in the emerging area of inflammasome science. The company specializes in research, development, and commercialization of therapies aimed at treating cancer and other diseases driven by inflammation. Flame Biosciences operates in the pharmaceutical and biotechnology market, serving patients who suffer from oncology and inflammatory conditions. The business model revolves around creating a pipeline of best-in-class assets with the potential to make a significant positive impact on patient health. Revenue is generated through the development and commercialization of these innovative therapies, as well as through strategic partnerships and financing activities. The company recently announced a $100 million common stock financing to further advance its drug development initiatives.

Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2017
Headquarters: New York City, United States
Employees: 1
Open positions: None listed
Dealroom signal: 24.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Jan 2023	$0	—	Leap Therapeutics	↗
EARLY VCOther financing	Oct 2020	$100M	$400M	Adage Capital · Rock Springs Capital · Citadel · Cormorant Asset Management	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Flame Biosciences website traffic

Latest recorded traffic for Flame Biosciences is 410 monthly website visits, down 31.7% over the last three months.

Latest monthly visits410 3-month web change-31.7%

Monthly website visitsOct 2020–Apr 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBioviva-scienceGene therapy and R&D company that targets cellular aging by developing new gene therapies to regenerate cells, muscles, and organs	United States	Operational	4	$250K	—
UDUniversal Medical Imaging DiagnosticOffers a holistic alternative and complementary approach to overall health that uses non-invasive, non-radioactive and painless imaging of the whole body	Los Angeles, United States	Operational
NHNavinata HealthNavinata Health is conveniently educating today's busy Physicians about innovative life-saving Therapies	Princeton, United States	Operational
PAPrecision Health AIPrecision Health AI is platform tech company that combines modern AI technology with best in class oncology data	New York City, United States	Operational
STSkyhawk TherapeuticsA drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression	Waltham, United States	Operational
OTOrbus TherapeuticsOrbus Therapeutics is dedicated to developing products that treat rare diseases	Palo Alto, United States	Operational
TBTeraFold BiologicsTeraFold Biologics is developing an integrated computational platform for discovery, modeling, and pre-clinical validation of alternative	San Francisco, United States	Operational
HBHarbour BioMedHarbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer	Cambridge, United States	Operational